ask="N/A"
ask_size="N/A"
average_daily_volume="263512"
bid="25.00"
bid_size="100"
book_value="7.07"
change="+0.67"
change_from_200_day_moving_average="0.92"
change_from_50_day_moving_average="1.08"
change_from_52_week_high="-6.80"
change_From_52_week_low="17.12"
change_in_percent="+2.13%"
close="32.12"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.26"
ebitda="-177.88M"
eps_estimate_current_year="-4.40"
eps_estimate_next_quarter="-1.10"
eps_estimate_next_year="-4.07"
ex_dividend_date="N/A"
float_shares="28541000"
high="32.33"
high_52_weeks="38.92"
last_trade_date="3/3/2017"
last_trade_price="32.12"
last_trade_size="23124"
last_trade_time="4:00pm"
low="31.28"
low_52_weeks="15.00"
market_capitalization="1.59B"
moving_average_200_day="31.20"
moving_average_50_day="31.04"
name="Theravance Biopharma
Inc."
notes="N/A"
one_year_target_price="34.86"
open="31.28"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="+2.95%"
percent_change_from_50_day_moving_average="+3.49%"
percent_change_from_52_week_high="-17.47%"
percent_change_from_52_week_low="+114.13%"
previous_close="31.45"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.45"
price_per_sales="32.05"
revenue="48.65M"
shares_outstanding="49569000"
short_ratio="19.05"
stock_exchange="NGM"
symbol="TBPH"
volume="258700"
weeks_range_52="15.00 - 38.92"
